Skip to content
Peptide.Guide

FDA Category 2 · restricted from compounding

This compound is on the FDA’s interim Section 503A Category 2 bulks list and cannot be legally compounded by US pharmacies. An HHS announcement in February 2026 signaled intent to restore several peptides to Category 1, but no Federal Register action has been published. Check the FDA PCAC schedule for updates.

Read the full regulatory context
PreclinicalTissue RepairOralDailyPartial data

BPC-157 (Capsules)

Oral capsule form of BPC-157, targeting gut healing where local action is desirable.

Read dosing protocol

§ 01   Overview

Overview

Oral capsule form of BPC-157, targeting gut healing where local action is desirable.

Oral dosing studied in rats for GI indications. No human trials.

§ 02   Mechanism

Mechanism of action

BPC-157 is naturally derived from a stable gastric protein and is thought to retain activity in the GI tract. Oral administration is particularly suited for gut-localized effects on the mucosa.

  • 01Localized gut healing support
  • 02Convenience over injections for GI indications

§ 03   Dosing

Dosing protocol

Standard Protocol

Dose Range
500 mcg 1–2x daily
Route
Oral
Frequency
Daily
Cycle
4–8 weeks

§ 04   Evidence

Evidence & research

Preclinical

Oral dosing studied in rats for GI indications. No human trials.

FDA Status

Not FDA-approved. On FDA 503A Negative List.

§ 05   Stacks

Common stacks

KPV

Gut healing combo

§ 06   News

In the news

4 articles from the last 12 months · updates hourly

§ 07   Sourcing

Sourcing & supply

Regulatory status

Restricted from compounding

Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales.

No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.

Browse full supplier directory

§ 09   Safety

Safety & side effects

Side effects

  • 01Generally well tolerated

Contraindications

None specified.

◆   In this categoryMore from Tissue Repair
01

BPC-157

Pentadecapeptide derived from a gastric protein; widely used in research and compounding for tendon, gut, and soft-tissue repair.

Preclinical
02

TB-500

Synthetic fragment of thymosin beta-4 promoting actin regulation, cell migration, and tissue repair.

Preclinical
03

GHK-Cu

Copper-binding tripeptide with broad effects on wound healing, collagen synthesis, and hair follicle function.

Clinical
04

KPV

Tripeptide fragment of alpha-MSH with potent anti-inflammatory effects, especially in the gut and skin.

Preclinical
05

BPC-157 + KPV (Capsules)

Combination oral capsule stacking BPC-157 and KPV for gut mucosal healing and anti-inflammatory effects.

Preclinical

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.